UHN Logo UHN Homepage Contact Us Links Search UHN Homepage PMH Homepage TWH Homepage TGH Homepage UHN disclaimer Links Contact Us UHN Home page Search UHN

Programs and ServicesAdvanced Medicine and SurgeryClinical ServicesCommunity and Population HealthHeart and CirculationMusculoskeletal Health and ArthritisNeural and Sensory SciencesOncology and Blood DisordersTransplantation

 

Advanced Medicine and Surgery

What is Advanced Medicine and Surgery?
Advanced Medicine and Surgery (AMS) is a program that not only treats patients, but also tries to better understand what causes diseases and how to improve treatments. The AMS program learns from patients and laboratory experiments and "translates" this learning into new treatments for patients with a wide range of complicated medical and surgical conditions.


"Part of the mission of the AMS group is to provide exemplary patient care for the most challenging medical and surgical conditions, while integrating cutting-edge research discoveries into day-to-day treatment."

- Dr. Charles Chan, Director, AMS

UHN's Advanced Medicine and Surgery Program (AMS)
Our AMS program provides expert care to patients with advanced organ-based conditions (for example kidney failure, lung disease, and digestive ailments), as well as diseases like HIV, hepatitis and diabetes. Patients are often referred to our program if other treatments have not been successful. Our multidisciplinary team helps assess the diagnosis and decide what the best treatment options are, looking to both established and experimental methods. Through research in our laboratories and clinical studies, we are able to bring innovative therapies to patients.

AMS Care Areas

Meeting new challenges with expertise and innovation
Combining research and patient care, we strive to improve patients' health and quality of life as much as possible. Key successes include:

  • Groundbreaking research in nighttime dialysis treatments for patients with kidney failure
  • International recognition for advances in the treatment of hepatitis B and C
  • Development of new therapies for interstitial lung diseases

Programs are also expanding for patients who are coping with disabilities or complications after treatment for cancer or transplantation. For example, a patient treated for cancer may be coping with a damaged liver, or a heart transplant patient may be coping with renal failure. Whatever the challenge, the AMS team sees each patient as a new opportunity to learn and help.

AMS Links:

LegalSite Map
UHN Homepage PMH Homepage TWH Homepage TGH Homepage UHN disclaimer